Aehr Test Systems (AEHR)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Aehr Test Systems.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 15 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 80.00 $ — 63% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
4 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -8.4% failed
- More than 10% revenue growth is expected for the coming year 70.9% passed
- Share count grows by less than 3% a year 1.6% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -26.0% failed
- Gross margin at 40% or higher and without meaningful erosion 35.3% failed
- Goodwill from acquisitions does not grow faster than revenue 4.4% passed
- Net debt below twice EBITDA 106 m net cash passed
- Operating cash flow covers the profits of the last three years -31 m failed
- Return on capital at 15% or higher, or up versus two years ago -6.2% failed
- Insiders hold at least 10% or are net buyers 4.6% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 43.8% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 2
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 05/31/2027 | 0.75 | 0.70 – 0.78 | 136 | 2,400.0% | 3 |
| 05/31/2028 | 1.38 | 1.13 – 1.54 | 202 | 84.4% | 3 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.09 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.03 | -116.90 | 14 | -37.20 | -7.60 | -6 | -6 |
| 2025: Q1 | -0.02 | – | 18 | 142.10 | -3.50 | -2 | -3 |
| 2025: Q2 | -0.10 | -112.00 | 14 | -15.10 | -20.60 | -2 | -5 |
| 2025: Q3 | -0.07 | -412.70 | 11 | -16.40 | -19.00 | 0 | -2 |
| 2025: Q4 | -0.11 | – | 10 | -26.50 | -32.70 | -1 | -2 |
| 2026: Q1 | -0.10 | – | 10 | -43.70 | -31.10 | -3 | -3 |
| 2026: Q2 | 0.05 | 150.00 | 19 | 33.30 | 7.40 | 2 | 2 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2017 | 19 | -5 | -6 | -0.35 | -5 | 17 | 31 |
| 2018 | 30 | 1 | 1 | 0.02 | -1 | 19 | 31 |
| 2019 | 21 | -4 | -5 | -0.23 | -6 | 15 | 21 |
| 2020 | 22 | -3 | -3 | -0.12 | -2 | 14 | 21 |
| 2021 | 17 | -4 | -2 | -0.09 | -3 | 11 | 22 |
| 2022 | 51 | 8 | 9 | 0.34 | 2 | 51 | 62 |
| 2023 | 65 | 13 | 15 | 0.50 | 10 | 76 | 98 |
| 2024 | 66 | 10 | 33 | 1.12 | 2 | 112 | 128 |
| 2025 | 59 | -4 | -4 | -0.13 | -7 | 123 | 149 |
| 2026 | 50 | -14 | -7 | -0.23 | -3 | 220 | 247 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Aehr Test Systems, Inc. bietet Testlösungen für Test, Burn-in und Halbleiterbauelemente auf Waferebene, vereinzelten Dies, Gehäuseteilen und installierten Systemen in den USA, Asien und Europa an.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 138 |
| Headquarters | Fremont, CA |
| Address | 400 Kato Terrace, 94539 Fremont, United States |
| Phone | 510 623 9400 |
| Website | aehr.com |
| IPO Date | 14. Aug 1997 |
| ISIN | US00760J1088 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Rhea J. Posedel | Founder & Independent Chairman | 1942 |
| Gayn Erickson | President, CEO & Director | 1964 |
| Chris P. Siu | CFO, Executive VP of Finance & Secretary | 1971 |
| Adil Engineer | Chief Operating Officer | 1977 |
| Donald P. Richmond II | Chief Technology Officer | 1956 |
| Vernon Rogers | Executive Vice President of Sales & Marketing | 1967 |
| Alberto Salamone | Executive Vice President of Packaged Parts Burn-in Business | – |
| Didier Wimmers | Executive Vice President of Research & Development | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 30. Jul 2026 | Slayen Howard T | Director | Other | 5,000 | 0.00 | – |
| 27. Jul 2026 | Erickson Gayn | President and CEO | Other | 1,057 | 77.48 | 81,896 |
| 27. Jul 2026 | Rogers Vernon | Exec VP of Sales & Mktg. | Other | 198 | 77.48 | 15,341 |
| 27. Jul 2026 | Sporck Alistair N | VP Contactor Business Unit | Other | 133 | 77.48 | 10,305 |
| 27. Jul 2026 | Richmond Donald P. Ii | CTO | Other | 102 | 77.48 | 7,903 |
| 27. Jul 2026 | Engineer Adil | Chief Operating Officer | Other | 142 | 77.48 | 11,002 |
| 21. Jul 2026 | Scott Geoffrey Gates | Director | Other | 2,874 | 0.00 | – |
| 20. Jul 2026 | Sporck Alistair N | VP Contactor Business Unit | Other | 334 | 81.05 | 27,071 |
| 16. Jul 2026 | Scott Geoffrey Gates | Director | Sell | 20,000 | 82.13 | 1,642,650 |
| 16. Jul 2026 | Scott Geoffrey Gates | Director | Other | 10,000 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.